Sen. Bernie Sanders (I-VT) on Saturday called for Health and Human Services Secretary Robert F. Kennedy Jr. to resign, escalating tensions within the federal government over public health leadership, scientific credibility, and trust in national health institutions. Sanders’ demand marks one of the most forceful rebukes yet from a senior lawmaker against Kennedy’s role overseeing the nation’s health agencies.
In a sharply worded statement, Sanders argued that Kennedy’s history of controversial views on vaccines and public health policy makes him unfit to lead the Department of Health and Human Services, which oversees agencies such as the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH). According to Sanders, the credibility of these institutions—and public confidence in them—is at stake.
“This is not about ideology or personality,” Sanders said. “It is about science, public trust, and the responsibility of government to protect people’s lives. We cannot have a Secretary of Health who undermines the very foundations of modern public health.”
Robert F. Kennedy Jr., a longtime environmental lawyer and political figure, has drawn scrutiny for years over statements questioning vaccine safety and criticizing pharmaceutical companies and federal health agencies. While Kennedy has argued that he supports vaccine choice and transparency rather than outright opposition, critics—including many public health experts—say his rhetoric has fueled misinformation and skepticism at a time when trust in health authorities is already fragile.
Sanders, who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee, emphasized that the United States is still grappling with the long-term consequences of the COVID-19 pandemic, including strained healthcare systems, workforce shortages, and lingering public distrust. In that context, he argued, leadership at HHS must be grounded firmly in evidence-based science.
“We need leadership that brings people together around facts, not leadership that deepens confusion and division,” Sanders said. “The stakes are too high for anything less.”
The call for resignation immediately sparked intense debate in Washington. Supporters of Sanders’ position praised him for drawing a clear line between free speech and the responsibility that comes with holding a powerful public office. Many public health advocates echoed his concerns, warning that mixed messages from the nation’s top health official could weaken vaccination efforts, disease prevention programs, and emergency preparedness.
“Words matter when you’re in charge of public health,” said one epidemiologist who has advised federal agencies. “Even subtle skepticism can have real-world consequences, especially in communities already vulnerable to misinformation.”
Others, however, pushed back strongly against Sanders’ demand. Kennedy’s supporters accused Sanders of political grandstanding and argued that Kennedy represents a long-overdue challenge to what they describe as excessive corporate influence within the healthcare system. They contend that questioning pharmaceutical companies and regulatory agencies should not automatically disqualify someone from public office.
“Calling for resignation because someone challenges powerful interests is dangerous,” said a spokesperson aligned with Kennedy. “Secretary Kennedy believes in transparency and accountability, and that’s exactly what the healthcare system needs.”
The White House has so far declined to comment directly on Sanders’ call for resignation, saying only that the administration stands by its commitment to public health and scientific integrity. Administration officials have previously defended Kennedy by pointing to internal advisory structures and career scientists within HHS who guide policy decisions.
Still, the controversy highlights a broader struggle over how public health should be governed in an era of polarization. Trust in health institutions declined sharply during the pandemic, with vaccines, masking, and lockdowns becoming deeply politicized. Lawmakers on both sides of the aisle agree that restoring confidence is critical—but they disagree on how to do it.
Sanders’ criticism reflects a long-standing concern he has voiced about misinformation and corporate power in healthcare. While he has frequently criticized pharmaceutical companies for high drug prices and profit-driven practices, he has also been clear that vaccines and public health interventions save lives and must be defended against disinformation.
“There is a difference between holding corporations accountable and undermining science,” Sanders said. “We can—and must—do both.”
Political analysts note that Sanders’ call for resignation could intensify scrutiny of Kennedy’s actions and statements moving forward, even if it does not immediately lead to his departure. Congressional hearings, oversight requests, and pressure from medical organizations could follow, especially if controversies continue.
“This puts a spotlight on every decision HHS makes,” said one congressional aide. “Whether Kennedy stays or goes, the department is now operating under a microscope.”
The episode also raises questions about the balance between dissent and responsibility in government leadership. Kennedy built much of his public profile by challenging institutions from the outside. As HHS Secretary, critics argue, he now represents those same institutions and must meet a different standard.
For Sanders, the issue ultimately comes down to public safety. “Millions of Americans depend on HHS for accurate information and effective policy,” he said. “If that trust is compromised, people get hurt.”
As of now, Robert F. Kennedy Jr. has not indicated any intention to resign. But Sanders’ call ensures that the debate over his leadership—and the future direction of U.S. public health—will remain front and center in the weeks ahead.
Leave a Reply